Commenting on the latest Urgent and Emergency Care Daily Situation Report 2021-22 that shows nearly one third of patients who were in hospital for 21 days or more were fit for discharge, Dr Katherine Henderson, President of the Royal College of Emergency Medicine, said:“These data reflect the deepening social care crisis.
“We currently have the highest number of long stay patients (21 days or more) since winter 2017-18. Last week, on average, 6,500 beds were occupied by patients who are fit for discharge, and only one in 10 of these patients were able to be discharged daily (on average). All these patients will want to return home and to their communities, but they are unable to because there isn’t the support to aid them upon their discharge.
“There must be a system-wide effort and focus on discharging patients, but such effort will only translate to meaningful action if the government address and take urgent steps to resource social care. Freeing up these beds would help alleviate system pressures, particularly those on Emergency Departments, and promote vital flow throughout the hospital.”
Plan B measures will be removed following millions getting the booster, which gives strong protection against Omicron
People will no longer be advised to work from home, face coverings will no longer be mandatory in indoor venues, and organisations will be able to choose whether to require NHS Covid Passes
Vaccination remains our best defence against COVID-19 and people are urged to Get Boosted Now
The UK government has announced that England will fully return to Plan A on Thursday 27 January thanks to the success of the booster programme, with ministers urging anyone who has still not had a top-up jab to come forward and Get Boosted Now.
On 8 December, the Prime Minister announced a move to Plan B following the rapid spread of the Omicron variant.
The measures introduced helped to control the spread of COVID-19, bought time to assess the variant and allowed the NHS to rapidly expand the booster programme to strengthen defences.
While vaccinations remain a priority, the success of the vaccination programme so far means we are now able to cautiously return to Plan A in England.
This means immediately (from yesterday, Wednesday 19 January):
The UK government is no longer asking people in England to work from home if they can. People should speak to their employers about arrangements for returning to the office, and should follow the Working Safely guidance.
From today (Thursday 20 January):
Face coverings will no longer be advised in classrooms for both staff and pupils.
From next Thursday (27 January):
Venues and events will no longer be required by law to use the NHS Covid Pass. The NHS Covid Pass can still be used on a voluntary basis as was previously the case in Plan A.
Face coverings are no longer required by law in any setting. Public health guidance will remain in place, suggesting individuals should continue to wear a face covering in crowded and enclosed spaces, where you may come into contact with people you do not normally meet.
The Department for Education will remove national guidance on the use of face coverings in communal areas, with local Directors of Public Health able to recommend the use of face coverings in education settings across their area only where the department and public health experts judge the measure to be proportionate due to specific health concerns. This is a temporary measure and Directors of Public Health continue to advise individual settings experiencing outbreaks.
Any local introduction of face coverings must be subject to routine review and removed at the earliest opportunity.
Throughout the pandemic, the UK government says it has maintained a balanced approach to COVID-19 measures, considering the freedoms of individuals together with the public health concerns of COVID-19.
Although the government is able to remove blanket restrictions, prevalence of COVID-19 is still high with over 16,000 people in hospital in England with the infection. As such individuals, employers and local leaders are urged to act cautiously and consider the risk of COVID-19 when moving back to Plan A. The guidance on gov.uk will be updated accordingly.
Due to the success of the booster programme, with over 30.5 million boosters given in England, the situation continues to improve.
The latest data from the UK Health Security Agency (UKHSA) shows that getting a booster is 89% effective in preventing hospitalisation from COVID-19 from two weeks after it is administered and is 65 to 75% effective against symptomatic infection from Omicron.
Vaccinations remain our best defence against COVID-19 and in December the Prime Minister launched a national appeal to Get Boosted Now. The government met its target of offering every eligible adult a booster jab by Christmas and now more than 4 in 5 (81%) of eligible adults in England have had their booster.
Over 90% of people aged 12 and above have had their first dose and over 83% have had their second. The government recently provided an extra £22.5 million to councils for Community Vaccine Champions to help drive uptake in harder-to-reach communities.
Health and Social Care Secretary Sajid Javid said: “Today marks the start of the next chapter in this country’s fight against COVID-19.
“Our plan was to use the time that Plan B gave us to give ourselves extra power in our fight against Omicron. That plan has worked, and the data shows that Omicron is in retreat.
“But it’s not the end of the road and we shouldn’t see this as the finish line. The best step that we can all take is to get vaccinated. It was the jabs that have got us this far, and the jabs can keep us here too”.
The vaccine programme is being bolstered by the development of world-leading antiviral treatments. In December, the Prime Minister confirmed a new national PANORAMIC study where 10,000 UK patients at risk of serious illness from COVID-19 will be given molnupiravir to treat their symptoms at home.
Testing also remains a vital tool in controlling the spread of COVID-19 and has allowed the government to take a proportionate approach to restoring individual freedoms.
Thanks to the accessibility of lateral flow tests (LFT), people self-isolating with COVID-19 can now end their isolation after five full days, provided they test negative on day 5 and 6. Contacts who are fully vaccinated can also avoid isolation by testing daily with LFTs and most of those who test positive on a LFT no longer have to confirm their case with a PCR test.
Education Secretary Nadhim Zahawi said: “Face-to-face education for all students has consistently been my priority, and that is why I am removing face coverings from classrooms – as promised – on the earliest possible date, making sure there is as little disruption to students’ learning as possible.
“National guidance to wear face coverings in communal areas will also be removed in line with the national move out of Plan B.
“Although we can take this action because we know the risk from Omicron is lower, the virus is still with us and proportionate protective measures remain vital to protect education. My message remains the same as ever – testing and vaccinations are our best weapons against the virus – keep testing, and get your vaccination as soon as possible.”
Chief Medical Advisor for the UK Health Security Agency, Dr Susan Hopkins said: “The recent decline in community case rates and individuals requiring hospitalisation is encouraging and it’s thanks to the public, who have taken up vaccination and followed the Plan B measures closely, that we’ve got to this point.
“However we should not be complacent. The pandemic is not over yet and we will need to remain cautious to reduce the spread of COVID-19 in our communities.
“I encourage everyone to get the vaccine as soon as they can, to continue testing regularly with LFTs – particularly before periods of high risk and before seeing anyone who is vulnerable – and to take a PCR test if they have symptoms.”
Government will set out a long term strategy for living with COVID-19 in due course.
Getting the right medicine to the right patient at the right time
Working with the UK’s largest dispensing robot, a team of unsung heroes have been making sure that patients across Greater Glasgow and Clyde get the medicines they need throughout the pandemic.
The team at the Pharmacy Distribution Centre in Glasgow process around 100,000 pharmacy items each week and, with the COVID-19 vaccination roll-out, that effort has expanded to include sending some 72,000 vaccines to clinics every week.
However, their herculean effort is aided by some Amazon-style technology and a huge, robot storage and distribution machine which automates around 80% of the pharmacy work.
The machine is believed to be the biggest of its kind, operating in the UK. At any one time, the Pharmacy Distribution Centre will carry some 10,000 lines of medicines. Work to distribute the vaccines remains a manual endeavour, with the team employed on that working in an adjacent site.
Claire Aliyar, Chief Pharmacy Technician at NHS Greater Glasgow and Clyde, explained: “The team have been working really hard throughout the pandemic – especially at the very beginning, because it just happened so fast. We tried to get as much stock in as we possibly could before it all started and we did manage to get some, but it was going out as soon as it came in.”
The team provide medicines for hospital wards, other acute settings, care homes and prison medical units. This includes major sites such as the Queen Elizabeth University Hospital and Glasgow Royal Infirmary, the Royal Alexandra Hospital in Paisley and the Inverclyde Royal Infirmary in Greenock.
Orders are placed online and the entire, high-tech production line works 24 hours a day, seven days a week. The team’s aim is to ensure that every patient gets the medicine they need, when they need it – with the robot dispensing medicines from amoxicillin to paracetamol (and everything in between) into blue boxes which are then tagged with the ward or location which has ordered them by a member of the team. The boxes are then packed into a fleet of vans ready to be shipped across the Greater Glasgow and Clyde area.
Technology is an important part of the process, and a few weeks before the first lockdown the team took delivery of a smaller robot, one which is refrigerated and can look after medicines that require being stored at cold temperatures. No other UK health board or trust currently has the same technology. The tech also helps to reduce to almost zero the number of errors that can occur in dispensing.
While the machines do much of the heavy lifting, a team of technicians and operatives ensure that the entire process runs smoothly, as was evidenced with the start of the pandemic.
When COVID arrived, the demand ramped up. Claire added: “The team were fabulous, they increased their working hours and came in for extra days. They just rolled up their sleeves, all with the same purpose – to get medicines out for the patients at their time of need.”
The team were then asked to set up a vaccine distribution centre from scratch.
Claire explained: “We did a small proportion of NHSGGC’s vaccine programme before, but nothing on the scale we needed. It became huge, a massive part of our workload and we took the new warehouse space from scratch and now we’re supplying more than 70,000 doses each week – more than 2.1 million doses to date.”
Ahead of the Omicron wave, the team worked to anticipate demand. Claire said: “The more prepared we are, the less pressure there is in the wards and departments.
“It’s been a huge success. I’ve never worked with a team like this – we all look out for each other whether we’re having a good or a bad day. We’ll always be here for each other and the patients, making sure their medication gets to them when they need it.”
Gail Caldwell, Director of Pharmacy for NHS Greater Glasgow and Clyde, added: “Medicines are the most common healthcare intervention and never has this been more important than during the pandemic.
“The pharmacy team at the Pharmacy Distribution Centre have worked tirelessly throughout to ensure NHSGGC had adequate supplies of critical medicines.”
The latest weekly update of Emergency Department performance figures for Scotland show:
There were 21,163 attendances at A&E services in NHS Scotland.
67.4% of attendances at A&E services were seen and resulted in a subsequent admission, transfer or discharge within 4 hours.
2,079 patients spent more than 8 hours in an A&E department.
690 patients spent more than 12 hours in an A&E department.
This data shows the worst weekly four-hour performance since records began. The highest number of (weekly) eight hour waits since records began, and the highest number of (weekly) 12-hour waits since records began.
More than one in eight patients were delayed in an Emergency Department by eight hours or more.
Responding to this data, Dr John Thomson, Vice President of the Royal College Emergency Medicine, Scotland, said: “This data is deeply concerning and distressing. More than one in eight patients have been delayed by eight hours or more; this is shocking.
The health service is in the middle of a serious crisis. Staff are working exceptionally hard but are burnt out and overwhelmed and face moral injury on every shift.
Patient safety is frequently compromised. We know long waiting times increase the risk of death and patient harm. The exit block that exists in our Emergency Departments which prevents patients moving in a safe, timely manner to an appropriate ward is worsening, causing even more harm to our patients.
“It is a critical time for the health service, and we must see a vision for the future. The government must acknowledge the shortfall in staff and beds as the root of this crisis, and this must lead to a commitment to publish a long-term workforce plan that includes measures to retain existing staff who may be thinking of leaving our NHS following this exceptionally challenging period.
“The government must also commit to opening 1,000 more acute beds across Boards in Scotland, which will promote timely patient flow through the hospital. Lastly, a key cause of exit block are the patients who remain in hospital when they no longer require ongoing Hospital care.
“The ongoing crisis in social care means patients are unable to be discharged home following the completion of their treatment. It is vital social care is resourced and adequately staffed to support the most vulnerable patients in their return to the community.”
Children aged five to 11 years old who have specific medical conditions which place them at greater risk from COVID-19 will be invited for their first vaccination from this week onwards.
Parents do not need to book an appointment for them online as they will be contacted directly by Health Boards.
Those five to 11 year olds who are household contacts of people with immune suppression will be invited to receive their vaccination in due course.
Letters will also be sent to young people aged 12-15 who are at particular clinical risk from COVID-19 inviting them for a booster jag, 12 weeks after their last primary dose.
Meanwhile, second doses are now available for all 12 to 15 year olds who had their first dose at least twelve weeks previously. This cohort can book an appointment online at NHS Inform or go to a drop-in centre. Parents and carers are welcome to accompany them..
Any 16 or 17 year old can book a booster online for 12 weeks after their second dose. They can also visit any drop-in centre.
Health Secretary Humza Yousaf said: “The vaccination programme continues to be a huge success and we are so grateful to all those who have taken up the offer of a vaccination and of course, every single person involved in the delivery of our national programme.
“In this next part of the programme we continue to deliver boosters and take forward the latest advice from the JCVI regarding younger cohorts. They and their parents can find out more about the vaccination that is recommended for each age group at NHS Inform.
“We urge all those who are eligible for any dose to take up the offer to protect them, those around them and of course our NHS at this particularly busy time.”
Public asked to remain cautious while case numbers are still high
Additional measures aimed at stemming the spread of the Omicron variant whilst the vaccination booster programme took effect will be lifted next week.
From 5am on Monday 24 January, restrictions including one metre physical distancing in hospitality and leisure settings and table service in hospitality venues will not be required and attendance limits at indoor events will be removed. Non-professional indoor contact sports will also resume.
Nightclubs can reopen and whilst the Covid certification scheme will not be extended at this stage, regulations will be updated to ensure venues cannot avoid the scheme by putting tables on dancefloors whilst still allowing dancing.
People will continue to be asked to work from home whenever possible, with employers asked to facilitate this. However, the Government will engage with businesses now about a return to a more hybrid approach from the start of February if case numbers continue to decline.
The guidance to keep social interaction at home and in indoor public places to a maximum of three households is also being lifted but given case numbers remain high, the public are being asked to be cautious and to limit contacts where possible, in addition to taking lateral flow tests before meeting people from other households.
Further baseline measures including a requirement to collect customer details in hospitality settings, the use of face coverings in public places and on public transport in addition to the current Covid certification scheme will remain in place to limit the spread of Omicron and reduce pressure on essential services.
First Minister Nicola Sturgeon said: “Because of the vaccination programme, and the efforts we have all made to curb transmission, our position is not as difficult as feared back in December. That is why we were able to lift the limits on outdoor events yesterday and why we are lifting other restrictions from next Monday.
“We are still in a very challenging position and the NHS remains under significant pressure, with the number of Covid cases still exceptionally high. Although we can be cautiously optimistic about our current position, we all still need to play our part in helping to slow the spread of the virus.
“The key ways in which all of us can do that include getting vaccinated as soon as you can, limiting and prioritising contacts that matter the most to you and taking lateral flow tests when you are planning to see other people.
“All of this makes a difference and is the reason why we have been able to start lifting restrictions and can look ahead to a much better spring and summer.”
“The health service is in the middle of the biggest crisis it has ever faced“
The latest monthly Emergency Department (ED) performance figures published by NHS England for December 2021 show that four-hour performance at major Emergency Departments reached its lowest since records began at 61.2%, meaning nearly two in five patients were delayed by four-hours or more and nearly 1 in 4 admissions experienced a wait of at least four hours from the decision to admit them to admission.
The data also show the highest number of 12 hour waits ever recorded: 12,986 patients spent 12 hours or more from decision to admit to admission. This is a 22% increase on the previous month, November 2021, and it is 250% higher than December 2020.
Responding to the publication of NHS England quarterly and monthly performance figures, Dr Katherine Henderson, President of the Royal College of Emergency Medicine, said:“The situation on the ground is extremely bleak. Staff are overwhelmed and burned out; it is increasingly challenging to provide timely and safe patient care.”
Latest Quarterly performance figures published by NHS England show that in 2021-2022 there were a total of 43,218 12-hour delays which is more than all the 12-hour delays over the previous ten years put together (39,608).
The data does not paint the full picture as NHS England record 12-hour waits from decision to admit. Our Winter Flow project, which started at the beginning of October 2021, has so far recorded 71,965 12-hour waits from time of arrival.
It is critical that NHS England commit to reporting 12-hour data from time of arrival and implement the Clinical Review of Standards.
Dr Henderson said:“The health service is in the middle of the biggest crisis it has ever faced, and staff are working harder than ever before with fewer staff and fewer beds.
“When the health service is overwhelmed, it does not cease to function, it is the standards and quality of care that fall. The figures published today show the extent to which these standards have fallen already.
“Performance metrics are intended to hold clinical services to account. They are meant to identify areas in which services are failing with the aim of improving them quickly and effectively.
“The consistent and continuous decline of urgent and emergency care performance, standards, patient experience and patient safety show how this intended function is now entirely lost. With each publication around performance, we commentate with shock and dismay at the latest decline, but our comments are, more often than not, met with inaction or short-term fixes. There needs to be acknowledgment that there is a major public health crisis in emergency care.
“It is the core ability and function of the health and social care service to deliver high-quality and effective care to the acutely ill or injured that is at risk.
“We must now see a vision for recovery and a vision for the health service that includes a vital transformation of the urgent and emergency care system. There must be a plan to implement a framework that is centred around patient care, that drives action and improvement.
“The current framework is simply documenting the health system’s failure to deliver a quality service, and the failure of this framework leaves urgent and emergency care in a performance vacuum.
“We need a decision about either a phased implementation of the findings of the Clinical Review of Standards or an honest discussion about how we performance manage urgent and emergency care differently.
“The current challenges facing the health and social care service are the result of years of stagnation and decline, they are made worse by, but are not just a consequence of, the pandemic. Recognising this is vital to any step towards transformation.
“It is time we saw bolder political willingness to engage on these critical issues. Without action, performance will continue to decline, and this would be a disservice to patients and staff.”
A defective gene, normally found in blood cancers, could be treated with drugs already available for cancers with similar gene defects, scientists at Queen’s University Belfast and the University of Birmingham have revealed.
The research team, funded mainly by Cancer Research UK and the Medical Research Council, found that tumours with mutations in the SF3B1 gene respond to PARP inhibitors, a type of drug used to treat cancers which have similar mutations in the BRCA1 and BRCA2 genes.
The researchers believe that PARP inhibitors could be used to treat patients with tumours carrying the defective SF3B1 gene. This mutation is most often found in blood cancers, including chronic lymphocytic leukaemia, as well as some rare cancers like uveal melanoma.
Dr Kienan Savage, lead author and Reader at the Patrick G Johnson Centre for Cancer Research at Queen’s, (above) said: “Our findings have clinical implications for the treatment of many cancers.
“We specifically focused on this genetic mutation as it is found in several difficult to treat leukaemias and other cancers, and it affects so many cancer patients. By deepening our understanding of this gene mutation, we have identified new ways of treating these cancers that could improve survival rates.”
PARP inhibitors, which include olaparib and rucaparib, are used to treat some patients with ovarian, breast, prostate and pancreatic cancers – usually patients who have inherited a faulty BRCA1 or BRCA2 gene. Around 1 in 400 people have a faulty BRCA1 or BRCA2 gene.
The research, published today in Cancer Research, a journal of the American Association for Cancer Research, found that the SF3B1 mutation produces similar effects to the faulty BRCA1 gene by damaging DNA, preventing it from being repaired properly, and stopping it from making normal copies of itself. PARP inhibitors target the cell’s DNA repair tools by locking them in place on the DNA. This stops DNA repair, causing the cancer cells to die.
The scientists found that cancer cells with the SF3B1 mutation were sensitive to olaparib, the most common PARP inhibitor, some specific chemotherapies and to radiotherapy. The scientists believe that the SF3B1 mutation disrupts the cell’s ability to make DNA repair proteins, leaving it vulnerable to drugs which target these proteins.
The SF3B1 mutation occurs in up to 30% of blood cancers called myelodysplastic syndromes, where blood cells don’t form properly. They are difficult to treat as they occur predominantly in older patients who may not be considered fit for treatment. The mutation is also common among uveal melanoma or cancers of the eye, which currently have limited treatment options.
Dr Katrina Lappin, from Queen’s and first author of the study, added: “Our research shows that cancers with these specific mutations, may be treated effectively with PARP inhibitor therapy drugs, which are less toxic, better at killing cancer cells with these mutations and can be taken at home in tablet form.This could have huge implications for improving outcomes and quality of life of people with these cancers.”
“This work will pave the way for clinical trials using PARP inhibitors for the treatment of patients with this commonly associated cancer mutation, allowing a more personalised approach to the treatment of these cancers.”
The researchers now want to test PARP inhibitors in clinical trials with patients who have the SF3B1 mutation to see if they can stop their cancer from spreading.
Co-author Professor Grant Stewart, of the University of Birmingham, said: “Our work demonstrates that a molecular understanding of how a specific gene mutation affects a cancer cell’s ability to repair damaged DNA can be exploited clinically to specifically tailor the anti-cancer therapy used to treat an individual’s tumour.
“This will increase the effectiveness of the therapy and hopefully, reduce the chances of re-occurrence.”
Michelle Mitchell, Chief Executive of Cancer Research UK, said: “Our scientists helped to discover the BRCA gene over 25 years ago and since then we’ve led the way in developing PARP inhibitors to treat cancers with BRCA gene faults.
“It’s really exciting to hear about a new mutation, which behaves like the BRCA1 mutation and could in the future be treated in the same way. With PARP inhibitors already widely available, there is huge potential to help people with some of the rarest and most difficult-to-treat cancers known to us.
“Over the past two decades, PARP inhibitors have saved thousands of lives worldwide, and it will be interesting to see if this research in the future could lead to a similar impact for people with rarer cancers.”
The research was funded by the UK Medical Research Council, Cancer Research UK, Blood Cancer UK, Leukaemia and Lymphoma NI and Great Ormond Street Hospital Children’s Charity.
More mental health and wellbeing services will be provided within GP practices and community settings, backed by investment of up to £40 million a year.
Under the new system, patients who need mental health support will find a range of professionals available through their doctor’s surgery, rather than having to rely solely on their GP or a referral elsewhere. These could include mental health nurses, psychologists, peer support workers, occupational therapists, and link workers.
Funding of £1.5 million has already been made available from the Mental Health Recovery and Renewal Fund. This will increase annually to support implementation of the new Mental Health and Wellbeing Primary Care Services, reaching an expected £40 million per year by 2024-25.
This could amount to more than £100 million by the end of this Parliament, substantially increasing the mental health workforce and transforming how support is delivered.
Minister for Mental Wellbeing Kevin Stewart said: “Mental ill health is one of the major public health challenges in Scotland. We know the pandemic has had a significant impact, which is why mental health has remained a priority throughout our response to COVID-19.
“Around a third of all GP consultations now has a mental health component. But the range and complexity of issues requires a more varied and comprehensive response.
“This new multi-disciplinary model will deliver our commitment to provide 1,000 additional dedicated mental health staff by 2026, supporting communities to improve their mental health.”
Deputy chair of BMA Scotland’s GP Committee Dr Andrew Cowie said: “Scotland’s mental health has suffered significantly throughout the COVID19 pandemic, and we welcome the additional mental health staff that will allow for our patients to access support within their communities.
“GP practices are most people’s first point of contact and it is important that there is a range of help and services available there. This is a welcome initiative and we look forward to working with the Scottish Government to develop the scheme and ensure all patients in Scotland can access better mental health in their communities.”
Local Planning Guidance, to support integration authorities and local partners to plan and implement the new services, will be published on the Scottish Government’s website this week.
Services will also link to community support such as addiction services, food banks and benefit support, through a link worker dedicated to each GP practice.
Pregnant women are being urged to Get Boosted Now in a new advertising campaign launched today over social media and radio
Pregnant women are being urged to Get Boosted Now in a New Year advertising drive launched today
New social media and radio assets highlight the risks of catching the virus and benefits of the vaccines to both mothers and their babies
Almost all pregnant women who were hospitalised or admitted to intensive care with COVID-19 were unvaccinated
Pregnant women who have not yet had their first, second, third or booster dose of a COVID-19 vaccine are being urged to get their jab as soon as possible, as the government launches a new advertising campaign for the New Year.
The new campaign joins forces with the experts at the Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Midwives (RCM) to highlight the serious risks of catching COVID-19 and the benefits the vaccines bring to protecting both mothers and their babies.
Testimonies of pregnant women who have had the jab to keep themselves safe will be played out in adverts across social media and radio stations across the country from today [Monday January 10].
The new campaign urges pregnant women ‘don’t wait to take the vaccine’ and highlights the risks of COVID-19 to mother and baby, and the benefits of vaccination.
The latest data from the UK Health Security Agency (UKHSA) shows COVID-19 vaccinations provide strong protection for pregnant women against the virus. It also shows the vaccines are safe for pregnant women, with similar birth outcomes for those who had the vaccine and those who had not.
DHSC Chief Scientific Adviser and Honorary Consultant Obstetrician Professor Lucy Chappell said: “Getting a COVID-19 vaccine is one of the most important things a pregnant woman can do this year to keep herself and her baby as safe from this virus as possible.
We have extensive evidence now to show that the vaccines are safe and that the risks posed by COVID-19 are far greater.
“If you haven’t had your COVID-19 vaccine, I would urge you to speak to your clinician or midwife if you have any questions or concerns, and book in your vaccine as soon as you can.”
Data from the UK Obstetric Surveillance System shows 96.3% of pregnant women admitted to hospital with COVID-19 symptoms between May and October 2021 were unvaccinated, a third of which (33%) requiring respiratory support. Around 1 in 5 women who are hospitalised with the virus need to be delivered preterm to help them recover and 1 in 5 of their babies need care in the neonatal unit.
The COVID-19 vaccines are safe for pregnant women and have no impact on fertility, which has been made extremely clear by the government, its senior clinicians and a range of independent experts from stakeholder groups such as RCOG the Royal College of Midwives (RCM) and the British Fertility Society.
Since April 2021, around 84,000 pregnant women have received one dose and over 80,000 have received two doses of the COVID-19 vaccine. In August 2021, only 22% of women who gave birth were vaccinated.
Dr Edward Morris, President of the Royal College of Obstetricians and Gynaecologists, said: “We welcome this national campaign as an important way of amplifying the very clear message to pregnant women that vaccination provides the best protection for both them and their babies from COVID-19. We urge all pregnant women to get vaccinated as soon as possible, and to get boosted 3 months after the second dose.
We are very concerned that many pregnant women have not yet been vaccinated against COVID-19 and we hope this campaign will help reassure them that vaccination is safe and effective. Pregnant women are more vulnerable of becoming seriously ill from COVID-19 infection, and this can lead to an increased risk of giving birth prematurely, and stillbirth.
“Gill Walton, Chief Executive and General Secretary of the Royal College of Midwives (RCM), said: There is overwhelming evidence that the COVID vaccine is safe for pregnant women and for their babies – and that it’s the best way to keep them safe from harm. Sadly, there are too many pregnant women being admitted to hospital with COVID, and 96.3% of them haven’t been vaccinated.
“The consequences of COVID when you are pregnant are clear and potentially devastated, from increased possibility of premature birth and admission to intensive care to a heightened risk of stillbirth.
“We know that pregnant women want to do everything they can to protect their baby, which is why midwives want to reassure them that vaccination is the best thing they can do.”
Dr Jen Jardine, from the Royal College of Obstetricians and Gynaecologists, who is also seven months pregnant and has had her COVID-19 booster jab, said: “Both as a doctor and pregnant mother myself, we can now be very confident that the COVID-19 vaccinations provide the best possible protection for you and your unborn child against this virus.
“I would strongly call on all pregnant women like me, if you haven’t had the vaccine yet, to either speak to your GP or midwife if you still have questions and then book right away today.”
